Kota Takuma#, Ayako Fuchigami#, Fumika Shigiyama, Naoki Kumashiro(Corresponding), Takahisa Hirose(Corresponding): Comparison of the effects of sitagliptin and dapagliflozin on time in range in Japanese patients with type 2 diabetes stratified by body mass index: a sub-analysis of the DIVERSITY-CVR study. Diabetes, Obesity and metabolism, 25:2131-2141, 2023 (#: Contributed equally)
Daisuke Koya, Stefan D Anker, Luis M Ruilope, Peter Rossing, ZhiHong Liu, Byung Wan Lee, Chien-Te Lee, Charlie Scott, Peter Kolkhof, Robert Lawatscheck, Lili Wang, Amer Joseph, Bertram Pitt(Corresponding); FIDELIO-DKD Investigators: Cardiorenal outcomes with finerenone in Asian patients with chronic kidney disease and type 2 diabetes: a FIDELIO-DKD post hoc analysis. American Journal of Nephrology, 54:370-378, 2023
2022年度
Hiruma S, Shigiyama F, Kumashiro N (Corresponding): Empagliflozin versus sitagliptin for ameliorating intrahepatic lipid content and tissue-specific insulin sensitivity in patients with early-stage type 2 diabetes with nonalcoholic fatty liver disease: A prospective randomized study. Diabetes Obes Metab 25:1576-1588, 2023
Hidaka N, Koga M, Kimura S, Hoshino Y, Kato H, Kinoshita Y, Makita N, Nangaku M, Horiguchi K, Furukawa Y, Ohnaka K, Inagaki K, Nakagawa A, Suzuki A, Takeuchi Y, Fukumoto S, Nakatani F, Ito N(Corresponding): Clinical challenges in diagnosis, tumor localization and treatment of tumor-induced osteomalacia: outcome of a retrospective surveillance. Journal of Bone and Mineral Research, 37: 1479-1488, 2022
Shimada K, Kanasaki K, Kato M, Ogura Y, Takagaki Y, Monno I, Hirai T, Kitada M, Koya D(Corresponding): Adenosine/adenosine type 1 receptor signaling pathway did not play dominant roles on the influence of sodium-glucose cotransporter 2 inhibitor in the kidney of bovine serum albumin-overloaded streptozotocin-induced diabetic mice. Journal of Diabetes Investigation, 13: 955-964, 2022
Xu J, Hirai T, Koya D, Kitada M (Corresponding): Effects of SGLT2 inhibitors on atherosclerosis: lessons from cardiovascular clinical outcomes in type 2 diabetic patients and basic researches. Journal of Clinical Medicine, 11: 137, 2022
Miyamoto S(Corresponding), Heerspink HJL, Zeeuw D, Toyoda M, Suzuki D, Hatanaka T, Nakamura T, Kamei S, Murao S, Hida K, Ando S, Akai H, Takahashi Y, Koya D, Kitada M, Sugano H, Nunoue T, Nakamura A, Sasaki M, Nakatou T, Fujimoto K, Kawanami D, Wada T, Miyatake N, Yoshida M, Shikata K, the CANPIONE study Investigators: Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE study. Diabetes, Obesity and Metabolism 24:1429-1438, 2022
2021年度
熊代教授関連
Ando Y, Shigiyama F, Hirose T, Kumashiro N (Corresponding): Simplification of complex insulin regimens using canagliflozin or liraglutide in patients with well-controlled type 2 diabetes: A 24-week randomized controlled trial. J Diabetes Investig 12: 1816-1826, 2021
Yoshikawa F, Kumashiro N, Shigiyama F, Miyagi M, Ando Y, Uchino H, Hirose T: Changes in subjective sleep quality in patients with type 2 diabetes who did not use Sleep agents: a cross‑sectional study according to age and clinical background. Diabetol Int: doi: org/10.1007/s13340-021-00516-3, 2021
Hiruma S#, Shigiyama F#, Hisatake S, Mizumura S, Shiraga N, Hori M, Ikeda T, Hirose T, Kumashiro N (Corresponding): A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study. Cardiovasc Diabetol 20: 32, 2021 (#: Contributed equally)
旧教室関連
Monno I, Ogura Y, Xu J, Koya D, Kitada M: Exercise ameliorates diabetic kidney disease in type 2 diabetic fatty rats. Antioxidants (Basel) 10: 11754 doi: 10.3390/antiox10111754, 2021
Kitada M, Koya D: Autophagy in metabolic disease and ageing. Nat Rev Endocrinol 17: 647-661, 2021
Hirai T, Kitada M, Monno I, Oda E, Hayashi Y, Shimada K, Takagaki Y, Ogura Y, Fujii M, Konishi K, Sakurai M, Nakagawa A, Koya D: Sodium-glucose cotransporter 2 inhibitors in type 2 diabetes patients with renal function impairment slow the annual renal function decline, in a real clinical practice. J Diabetes Investig 12: 1577-1585, 2021
Fujii M, Nakagawa A, Tachibana O, Iizuka H, Koya D: Anterior pituitary function in Rathke's cleft cysts versus nonfunctioning pituitary adenomas. Endocr J 68: 943-952, 2021
Ogura Y, Kitada M, Koya D: Sirtuins and renal oxidative stress. Antioxidants (Basel) 10: 1198 doi: org/10.3390/antiox10081198, 2021
Xu J, Kitada M, Koya D: NAD⁺ homeostasis in diabetic kidney disease. Front Med (Lausanne) 8: 703076 doi: 10.3389/fmed.2021.703076, 2021
Kumagai A,Takeda S, Sohara E, Uchida S, Iijima H, Itakura A, Koya D, Kanasaki K: Dietary magnesium insufficiency induces salt-sensitive hypertension in mice associated with reduced kidney catechol-o-methyl transferase activity. Hypertension 78: 138-150, 2021
Srivastava SP, Goodwin JE, Tripathi P, Kanasaki K, Koya D: Interactions among long non-coding RNAs and microRNAs influence disease phenotype in diabetes and diabetic kidney disease. Int J Mol Sci 22: 6027 doi: 10.3390/ijms22116027, 2021
Xu J, Kitada M, Ogura Y, Liu H, Koya D: Dapagliflozin restores impaired autophagy and suppresses inflammation in high glucose-treated HK-2 cells. Cells 10: 1457 doi:10.3390/cells10061457, 2021
Kawakita E, Koya D, Kanasaki K: CD26/DPP-4: type2 diabetes drug target with potential influence on canner biology. Cancers (Basel) 13: 2191, 2021
Liu H, Takagaki Y, Kumagai A, Kanasaki K, Koya D: The PKM2 activator TEPP-46 suppresses kidney fibrosis via inhibition of the EMT program and aberrant glycolysis associated with suppression of HIF-1α accumulation. J Diabetes Investig 12: 697-709, 2021
Xu J, Kitada M, Ogura Y, Koya D: Relationship between autophagy and metabolic syndrome Characteristics in the pathogenesis of atherosclerosis. Front Cell Dev Biol 9: 641852 doi: 10.3389/fcell.2021.641852, 2021
Srivastava SP, Zhou H, Setia O, Liu B, Kanasaki K, Koya D, Dardik A, Fernandez-Hernando C, Goodwin J: Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy. Nat Commun 12: 2368 doi: 10.1038/s41467-021-22617-y, 2021
Srivastava SP, Li J, Takagaki Y, Kitada M, Goodwin J E, Kanasaki K, Koya D: Endothelial SIRT3 regulates myofibroblast metabolic shifts in diabetic kidneys. iScience 24: 102390 doi: org/10.1016/j.isci.2021.102390, 2021
Kawakita E, Yang F, Kumagai A, Takagaki Y, Kitada M, Yoshitomi Y, Ikeda T, Nakamura Y, Ishigaki I, Kanasaki k, Koya D: Metformin mitigates DPP-4 inhibitor-induced breast cancer metastasis via suppression of mTOR signaling. Mol Cancer Res 19: 61-73, 2021
Kitada M, Ogura Y, Monno I, Xu J, Koya D: Effect of methionine restriction on aging: its relationship to oxidative stress. Biomedicines 9: 130 doi: 10.3390/biomedicines9020130, 2021